News

  • From D25 to Nirsevimab: A Dutch Discovery that Changed Infant Health Worldwide
    From D25 to Nirsevimab: A Dutch Discovery that Changed Infant Health Worldwide In 2007, a breakthrough in respiratory medicine was made in Amsterdam. Prof. Hergen Spits and his team, isolated a potent antibody, D25, from a single immune cell of a Dutch blood donor. This antibody targeted the respiratory syncytial virus (RSV), a common cold virus that poses a serious threat to infants. Today, its optimized successor, nirsevimab, is part of the national immunization program, preventing thousands of hospitalizations each year in the Netherlands and beyond.
  • Cognitive screening and daily functioning in dementia
    Cognitive screening and daily functioning in dementia A recent study using data from the Amsterdam Dementia Cohort shows that cognitive screening scores are only moderately related to everyday functioning, highlighting the importance of combining cognitive and functional assessments in Alzheimer’s disease research and care.
  • Two ACH Fellowships Awarded to Early-Career Researchers
    Two ACH Fellowships Awarded to Early-Career Researchers Amsterdam Cohort Hub has awarded two fellowships to support early-career researchers in developing multicohort grant proposals. The 2025 fellowships have been granted to Robert Jertberg and Noreen Siddiqui.